Rocket One Inc. Common Stock (NASDAQ:RKTO) Stock Price Down 5.2% – Should You Sell?

Rocket One Inc. Common Stock (NASDAQ:RKTO)’s stock price dropped 5.2% during mid-day trading on Wednesday . The stock traded as low as $0.94 and last traded at $0.9482. Approximately 495,041 shares were traded during trading, a decline of 92% from the average daily volume of 5,940,086 shares. The stock had previously closed at $1.00.

Analyst Upgrades and Downgrades

RKTO has been the topic of several recent analyst reports. Weiss Ratings upgraded Rocket One Inc. Common Stock from a “sell (e+)” rating to a “sell (d-)” rating in a report on Tuesday, June 23rd. D. Boral Capital reaffirmed a “buy” rating and issued a $5.00 price objective on shares of Rocket One Inc. Common Stock in a research report on Wednesday, March 25th. Finally, Wall Street Zen upgraded Rocket One Inc. Common Stock from a “strong sell” rating to a “sell” rating in a research note on Saturday, May 30th. One research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $5.00.

Rocket One Inc. Common Stock Price Performance

The stock’s 50-day moving average price is $1.01 and its 200 day moving average price is $0.96. The firm has a market capitalization of $21.16 million, a PE ratio of -1.19 and a beta of 0.93.

Rocket One Inc. Common Stock (NASDAQ:RKTO) last announced its quarterly earnings data on Friday, May 15th. The company reported ($0.17) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by ($0.03).

Hedge Funds Weigh In On Rocket One Inc. Common Stock

Several institutional investors have recently made changes to their positions in RKTO. DRW Securities LLC purchased a new stake in Rocket One Inc. Common Stock in the fourth quarter worth about $257,000. Citadel Advisors LLC purchased a new position in Rocket One Inc. Common Stock during the 3rd quarter valued at about $232,000. Virtu Financial LLC bought a new stake in shares of Rocket One Inc. Common Stock in the 3rd quarter valued at about $184,000. Kestra Private Wealth Services LLC bought a new stake in shares of Rocket One Inc. Common Stock in the 3rd quarter valued at about $51,000. Finally, Geode Capital Management LLC lifted its position in shares of Rocket One Inc. Common Stock by 18.0% in the 4th quarter. Geode Capital Management LLC now owns 181,112 shares of the company’s stock worth $179,000 after purchasing an additional 27,577 shares during the period. Hedge funds and other institutional investors own 7.08% of the company’s stock.

Rocket One Inc. Common Stock Company Profile

Hoth Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on the acquisition, licensing and development of novel therapies for dermatological, central nervous system and other debilitating conditions. The company’s strategy emphasizes in-licensing late preclinical or early clinical assets with promising pharmacological profiles and leveraging formulation science to optimize delivery. Core to its approach is the design of topical and localized administration platforms intended to enhance drug penetration, sustain release and reduce systemic exposure.

Hoth’s development pipeline encompasses multiple candidate programs addressing high-unmet-need areas such as atopic dermatitis, epidermolysis bullosa and oral mucositis.